Sex difference in appropriate shocks but not mortality during long-term follow-up in patients with implantable cardioverter-defibrillators

Europace

Volumn 18, Issue 8, 2016, Pages 1194-1202

  Seegers, Joachim ^a   Conen, David ^b   Jung, Klaus ^a   Bergau, Leonard ^a   Dorenkamp, Marc ^c   Lüthje, Lars ^a   Sohns, Christian ^a   Sossalla, Samuel T ^a,d   Fischer, Thomas H ^a,d   Hasenfuss, Gerd ^a,d   Friede, Tim ^a,d   Zabel, Markus ^a,d  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

Cardiovascularmortality; Implantable cardioverter defibrillator; Risk factors; Sex difference; Sudden cardiac death

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MINERALOCORTICOID ANTAGONIST; WARFARIN;

ADULT; AGE; AGED; ARTICLE; CARDIAC PATIENT; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFOUNDING VARIABLE; DIURETIC THERAPY; DUAL CHAMBER PACEMAKER; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INDEPENDENT VARIABLE; KIDNEY FUNCTION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PACEMAKER IMPLANTATION; PATIENT SELECTION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SECONDARY PREVENTION; SEX DIFFERENCE; SINGLE CHAMBER PACEMAKER; SUDDEN CARDIAC DEATH; SURVIVAL PREDICTION; TREATMENT INDICATION; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR DISEASES; DEATH, SUDDEN, CARDIAC; GERMANY; KAPLAN MEIER METHOD; MORTALITY; MULTIVARIATE ANALYSIS; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR DISEASES; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS;

EID: 84982170361     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euv361     Document Type: Article

References (34)

1. The Antiarrhythmics AVID Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-83
2. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999;341:1882-90
3. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83
4. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37
5. Tung R, Zimetbaum P, Josephson ME. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol 2008;52:1111-21
6. Goldenberg I, Vyas AK, Hall WJ, Moss AJ,Wang H, He H et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 2008;51:288-96
7. Koller MT, Schaer B,Wolbers M, Sticherling C, Bucher HC, Osswald S. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study. Circulation 2008;117:1918-26
8. Zareba W, Moss AJ, Jackson Hall W, Wilber DJ, Ruskin JN, McNitt S et al. Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction. J Cardiovasc Electrophysiol 2005;16:1265-70
9. Russo AM, Poole JE, Mark DB, Anderson J, Hellkamp AS, Lee KL et al. Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial. J Cardiovasc Electrophysiol 2008;19:720-4
10. Albert CM, Quigg R, Saba S, Estes NA 3rd, Shaechter A, Subacius H et al. Sex differences in outcome after implantable cardioverter defibrillator implantation in nonischemic cardiomyopathy. Am Heart J 2008;156:367-72
11. MacFadden DR, Crystal E, Krahn AD, Mangat I, Healey JS, Dorian P et al. Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database. Ann Intern Med 2012;156:195-203
12. van der Heijden AC, Thijssen J, Borleffs CJ, van Rees JB, Hoke U, van der Velde ET et al. Gender-specific differences in clinical outcome of primary prevention implantable cardioverter defibrillator recipients. Heart 2013;99:1244-9
13. Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007;53:766-72
14. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999;94:496-509
15. van Buuren S, Boshuizen HC, Knook DL. Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med 1999;18:681-94
16. van Buuren S, Groothuis-Oudshoorn K. Multivariate Imputation by Chained Equations in R. J Stat Softw 2011;45:1-67
17. Pocock SJ, Ariti CA, McMurray JJ, Maggioni A, Kober L, Squire IB et al. Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. Eur Heart J 2013;34:1404-13
18. Therneau TM, Grambsch PM. Stratified Cox models. In. Modeling Survival Data: Extending the Cox Model. New York: Springer; 2000, 44-7
19. Peterson PN, Daugherty SL, Wang Y, Vidaillet HJ, Heidenreich PA, Curtis JP et al. Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy. Circulation 2009;119:1078-84
20. Haigney MC, ZarebaW, Nasir JM, McNitt S, McAdams D, Gentlesk PJ et al. Gender differences and risk of ventricular tachycardia or ventricular fibrillation. Heart Rhythm 2009;6:180-6
21. Drici MD, Burklow TR, Haridasse V, Glazer RI, Woosley RL. Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart. Circulation 1996;94:1471-4
22. Korte T, Fuchs M, Arkudas A, Geertz S, Meyer R, Gardiwal A et al. Female mice lacking estrogen receptor beta display prolonged ventricular repolarization and reduced ventricular automaticity after myocardial infarction. Circulation 2005;111: 2282-90
23. Airaksinen KE, Ikaheimo MJ, Linnaluoto M, Tahvanainen KU, Huikuri HV. Gender difference in autonomic and hemodynamic reactions to abrupt coronary occlusion. J Am Coll Cardiol 1998;31:301-6
24. Kannel WB, Wilson PW, D'Agostino RB, Cobb J. Sudden coronary death in women. Am Heart J 1998;136:205-12
25. Wigginton JG, Pepe PE, Bedolla JP, DeTamble LA, Atkins JM. Sex-related differences in the presentation and outcome of out-of-hospital cardiopulmonary arrest: a multiyear, prospective, population-based study. Crit Care Med 2002;30:S131-6
26. Ghanbari H, Dalloul G, Hasan R, Daccarett M, Saba S, David S et al. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Arch Intern Med 2009;169:1500-6
27. Santangeli P, Pelargonio G, Dello Russo A, Casella M, Bisceglia C, Bartoletti S et al. Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: a systematic review and meta-analysis. Heart Rhythm 2010;7:876-82
28. Bergau L, Seegers J, ZabelM. Sex differences in ICD benefit. J Electrocardiol 2014;47: 869-73
29. Wijers SC, van der Kolk BY, Tuinenburg AE, Doevendans PA, Vos MA, Meine M. Implementation of guidelines for implantable cardioverter-defibrillator therapy in clinical practice: Which patients do benefit? Neth Heart J 2013;21:274-83
30. Weeke P, Johansen JB, Jorgensen OD, Nielsen JC, Moller M, Videbaek R et al. Mortality and appropriate and inappropriate therapy in patients with ischaemic heart disease and implanted cardioverter-defibrillators for primary prevention: data from the Danish ICD Register. Europace 2013;15:1150-7
31. Zabarovskaja S, Gadler F, Braunschweig F, Stahlberg M, Hornsten J, Linde C et al. Women have better long-term prognosis than men after cardiac resynchronization therapy. Europace 2012;14:1148-55
32. Connolly SJ. Use and misuse of surrogate outcomes in arrhythmia trials. Circulation 2006;113:764-6
33. Kramer DB, Friedman PA, Kallinen LM, Morrison TB, Crusan DJ, Hodge DO et al. Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillators. Heart Rhythm 2012;9: 42-6
34. Bilchick KC, Stukenborg GJ, Kamath S, Cheng A. Prediction of mortality in clinical practice for medicare patients undergoing defibrillator implantation for primary prevention of sudden cardiac death. J Am Coll Cardiol 2012;60: 1647-55